Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 14, 2020 04:38PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
A buyout probably would make it go away but probably not a partnership.